UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Sep 10, 2026
Sale
Calculated transaction value
$595.77K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Sep 9, 2026
Public filing date
Sep 10, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$506.82
Sep 9, 2026
Close before public filing
$506.82
Sep 9, 2026
Return since public filing
-1.92%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,202 shares @ $495.65
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000138
Filing cohort
Transactions in this filing
Showing 15 of 16
Trades
16
Issuers
1
Estimated value
$5.89M
Buys / sales
0 / 14
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Sep 9, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Sep 9, 2026 | $39.5K |
| United Therapeutics Corp UTHR Current | Sale | Sep 9, 2026 | $595.77K |
| United Therapeutics Corp UTHR | Sale | Sep 9, 2026 | $634.82K |
| United Therapeutics Corp UTHR | Sale | Sep 9, 2026 | $79.61K |
| United Therapeutics Corp UTHR | Sale | Sep 9, 2026 | $199.54K |
| United Therapeutics Corp UTHR | Sale | Sep 9, 2026 | $259.36K |
| United Therapeutics Corp UTHR | Sale | Sep 9, 2026 | $180.8K |
| United Therapeutics Corp UTHR | Sale | Sep 9, 2026 | $511.41K |
| United Therapeutics Corp UTHR | Sale | Sep 9, 2026 | $576.12K |
| United Therapeutics Corp UTHR | Sale | Sep 9, 2026 | $486.85K |
| United Therapeutics Corp UTHR | Sale | Sep 9, 2026 | $442.56K |
| United Therapeutics Corp UTHR | Sale | Sep 9, 2026 | $402.43K |
| United Therapeutics Corp UTHR | Sale | Sep 9, 2026 | $256.88K |
| United Therapeutics Corp UTHR | Sale | Sep 9, 2026 | $101.8K |